Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016


  • Products Id :- GDME0234EPD
  • |
  • Pages: 70
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016" provides an overview of Bone Growth Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Growth Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bone Growth Stimulators under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Bone Growth Stimulators under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Bone Growth Stimulators Overview 6

3 Products under Development 7

3.1 Bone Growth Stimulators - Pipeline Products by Stage of Development 7

3.2 Bone Growth Stimulators - Pipeline Products by Segment 8

3.3 Bone Growth Stimulators - Pipeline Products by Territory 9

3.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path 10

3.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date 11

4 Bone Growth Stimulators - Pipeline Products under Development by Companies 12

4.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development 12

4.2 Bone Growth Stimulators - Pipeline Products by Stage of Development 13

5 Bone Growth Stimulators Companies and Product Overview 14

5.1 Bionext Biotech Products Ltd. Company Overview 14

5.1.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Curative Biosciences, Inc. Company Overview 15

5.2.1 Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Forticell Bioscience, Inc. Company Overview 17

5.3.1 Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 GreenBone Ortho srl Company Overview 18

5.4.1 GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Induce Biologics Inc. Company Overview 19

5.5.1 Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 KeraCure, Inc. (Inactive) Company Overview 20

5.6.1 KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20

5.7 Locate Therapeutics Limited Company Overview 21

5.7.1 Locate Therapeutics Limited Pipeline Products & Ongoing Clinical Trials Overview 21

5.8 Osiris Therapeutics, Inc. Company Overview 22

5.8.1 Osiris Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.9 OsteoGenix Incorporated (Inactive) Company Overview 24

5.9.1 OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.10 REGENECURE, Ltd. Company Overview 25

5.10.1 REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

5.11 Scil Technology GmbH (Inactive) Company Overview 27

5.11.1 Scil Technology GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.12 Taxus Cardium Pharmaceuticals Group Inc. Company Overview 30

5.12.1 Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 Tornier, Inc. Company Overview 32

5.13.1 Tornier, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 Zimmer Biomet Holdings, Inc. Company Overview 33

5.14.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

6 Bone Growth Stimulators- Recent Developments 35

6.1 Sep 16, 2016: Osiris Provides Update Regarding NASDAQ Listing Status 35

6.2 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 35

6.3 Sep 14, 2016: Nanovis to Raises USD3.8 Million in Venture Financing 36

6.4 Sep 13, 2016: Nanovis Raises USD1.1 Million in Venture Financing 36

6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 36

6.6 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate 39

6.7 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results 39

6.8 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 42

6.9 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 42

6.10 Jul 26, 2016: Globus Medical Reports Second Quarter 2016 Results 43

6.11 Jul 21, 2016: Stryker reports second quarter 2016 results 44

6.12 Jul 19, 2016: Bioventus Withdraws IPO 45

6.13 Jul 06, 2016: Bone Biologics Names Scott D. Boden, MD Chief Medical Advisor 45

6.14 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 46

6.15 Jun 29, 2016: New chairman appointed at JRI Orthopaedics 46

6.16 Jun 27, 2016: Greatbatch Renamed Integer Holdings 47

6.17 Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers 48

6.18 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 48

6.19 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes 48

6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 49

6.21 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 49

6.22 May 03, 2016: Globus Medical Reports First Quarter 2016 Results 52

6.23 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 52

6.24 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 54

6.25 Feb 25, 2016: Orthofix Study Shows Pulsed Electromagnetic Field Therapy May Reduce Cellular Inflammation Associated with Disc Degeneration 57

6.26 Feb 24, 2016: Globus Medical Reports Full Year and Fourth Quarter 2015 Results 58

6.27 Jan 19, 2016: Globus Medical Announces Litigation Settlement Agreement 59

6.28 Jan 12, 2016: Antibe Therapeutics Enters into Licensing Agreement with Induce Biologics 59

6.29 Jan 11, 2016: Bioventus Board of Managers Appoints Bill Hawkins Chairman 59

6.30 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 60

6.31 Jan 06, 2016: Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results 60

6.32 Dec 03, 2015: Cytos Biotech Merges with Kuros Biosurgery 61

6.33 Dec 03, 2015: Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences 61

6.34 Nov 11, 2015: Kuros Biosurgery Raises Additional USD5 Million Financing 62

6.35 Nov 03, 2015: Globus Medical Reports Third Quarter 2015 Results 62

6.36 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 63

6.37 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 66

7 Appendix 67

7.1 Methodology 67

7.2 About GlobalData 69

7.3 Contact Us 69

7.4 Disclaimer 70

1.2 List of Figures

Figure 1: Bone Growth Stimulators - Pipeline Products by Stage of Development 7

Figure 2: Bone Growth Stimulators - Pipeline Products by Segment 8

Figure 3: Bone Growth Stimulators - Pipeline Products by Territory 9

Figure 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path 10

Figure 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date 11

1.1 List of Tables

Table 1: Bone Growth Stimulators - Pipeline Products by Stage of Development 7

Table 2: Bone Growth Stimulators - Pipeline Products by Segment 8

Table 3: Bone Growth Stimulators - Pipeline Products by Territory 9

Table 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path 10

Table 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date 11

Table 6: Bone Growth Stimulators Companies - Pipeline Products by Stage of Development 12

Table 7: Bone Growth Stimulators - Pipeline Products by Stage of Development 13

Table 8: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Orthonext - Product Status 14

Table 10: Orthonext - Product Description 14

Table 11: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: Nurture BSP - Product Status 15

Table 13: Nurture BSP - Product Description 15

Table 14: Osteoconductive Scaffold - Product Status 16

Table 15: Osteoconductive Scaffold - Product Description 16

Table 16: Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

Table 17: Haptides Bone Regeneration - Product Status 17

Table 18: Haptides Bone Regeneration - Product Description 17

Table 19: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview 18

Table 20: GreenBone Implant - Product Status 18

Table 21: GreenBone Implant - Product Description 18

Table 22: Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 23: URIST - Product Status 19

Table 24: URIST - Product Description 19

Table 25: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20

Table 26: KeraPac - Bone Regeneration - Product Status 20

Table 27: KeraPac - Bone Regeneration - Product Description 20

Table 28: Locate Therapeutics Limited Pipeline Products & Ongoing Clinical Trials Overview 21

Table 29: Injectable Bone Graft - Product Status 21

Table 30: Injectable Bone Graft - Product Description 21

Table 31: Osiris Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 32: Osteocel XC - Product Status 22

Table 33: Osteocel XC - Product Description 23

Table 34: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Table 35: Bone Anabolic Agent - Product Status 24

Table 36: Bone Anabolic Agent - Product Description 24

Table 37: REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

Table 38: Regenecure AMCA GBR Bone Membrane Implant - Product Status 25

Table 39: Regenecure AMCA GBR Bone Membrane Implant - Product Description 26

Table 40: Scil Technology GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

Table 41: ST03 Activated Implant - Product Status 27

Table 42: ST03 Activated Implant - Product Description 27

Table 43: ST04 Activated Injectable - Product Status 28

Table 44: ST04 Activated Injectable - Product Description 28

Table 45: ST05 - Product Status 29

Table 46: ST05 - Product Description 29

Table 47: Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 48: Osteorate - Product Status 30

Table 49: Osteorate - Product Description 31

Table 50: Tornier, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

Table 51: Soft Tissue Graft - Product Status 32

Table 52: Soft Tissue Graft - Product Description 32

Table 53: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 54: OrthoPak III - Product Status 33

Table 55: OrthoPak III - Product Description 34

Table 56: SpinalPak III - Product Status 34

Table 57: SpinalPak III - Product Description 34

Table 58: Glossary 68

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Bionext Biotech Products Ltd.

Curative Biosciences, Inc.

Forticell Bioscience, Inc.

GreenBone Ortho srl

Induce Biologics Inc.

KeraCure, Inc.

Locate Therapeutics Limited

Osiris Therapeutics, Inc.

OsteoGenix Incorporated

REGENECURE, Ltd.

Scil Technology GmbH

Taxus Cardium Pharmaceuticals Group Inc.

Tornier, Inc.

Zimmer Biomet Holdings, Inc.

select a license

Single User License
USD 2500 INR 181300
Site License
USD 5000 INR 362600
Corporate User License
USD 7500 INR 543900

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com